Join CarboHyde for the 11th edition of its flagship Masterclass series—an expert-led deep dive into parenteral cyclodextrin applications.
Event registration:
CarboHyde’s Cyclodextrin Masterclass XI – Parenteral Applications of Cyclodextrins – CarboHyde
This advanced, practice-oriented session explores how cyclodextrins enable safe, effective injectable formulations across small molecules and biologics, including protein therapeutics and vaccines.
The Masterclass blends scientific fundamentals, hands-on formulation strategy, and real-world case studies, addressing both opportunities and limitations while highlighting emerging directions in the field.
What You’ll Learn
Parenteral-grade cyclodextrins: selection criteria, quality attributes, and regulatory expectations
Formulation development & optimization: solubility enhancement, stability, compatibility, and excipient interactions
Biologics-focused insights: protein stabilization, aggregation control, vaccine formulation considerations
Small-molecule injectables: complexation strategies, safety margins, and performance trade-offs
Case studies: successes, pitfalls, and decision frameworks from development to scale-up
Limitations & risk management: toxicity thresholds, dosing constraints, and formulation boundaries
What’s next: novel derivatives, new indications, and innovation pathways
Who Should Attend?
This Masterclass is designed for professionals working in or transitioning to parenteral drug development, including:
Formulation Scientists & R&D Leaders (small molecules and biologics)
CMC, Pharmaceutical Development & Technical Operations Teams
Vaccine Developers & Protein Scientists
Drug Delivery & Enabling Technology Specialists
Regulatory Affairs & Quality Professionals
Project Managers & Decision-Makers evaluating injectable formulation strategies
Why You’ll Benefit
Practical, decision-ready knowledge: Move beyond theory to actionable formulation strategies
Cross-modality perspective: Understand how cyclodextrins behave differently with proteins, vaccines, and small molecules
Risk-aware development: Learn where cyclodextrins add value—and where they may not
Accelerated development timelines: Apply proven approaches to reduce iteration cycles
Future-proof insights: Stay ahead of regulatory, technological, and clinical trends
Format & Experience
Live, expert-led online session
Structured learning + applied examples
Interactive discussion and Q&A
Comprehensive takeaways you can apply immediately in development programs
Key Topics at a Glance
Parenteral excipient requirements
Cyclodextrin–API and cyclodextrin–protein interactions
Stability, safety, and scalability
Clinical and commercial considerations
Innovation beyond current standards
Who It’s For (In One Line)
If you develop, evaluate, or make decisions about injectable formulations—from early R&D to late-stage programs—this Masterclass is built for you.